4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-047656
Director sold 26,000 shares at $14.47 ($376,282)
- Director acquired 26,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2018-08-30 | Option exercise | +8,000 | $2.10 | $16,800 | 133,046 | D |
| Kraus Al Director | 2018-08-30 | Option exercise | +18,000 | $4.20 | $75,600 | 151,046 | D |
| Kraus Al Director | 2018-08-30 | Sale | −26,000 | $14.47 | $376,282 | 125,046 | D |
| Derivatives | |||||||
| Kraus Al Director | 2018-08-30 | Option exercise · Stock Option (right to buy) | −8,000 | 0 | D | ||
| Kraus Al Director | 2018-08-30 | Option exercise · Stock Option (right to buy) | −18,000 | 0 | D | ||
| Open-market sales · 26,000 sh · avg $14.47 · $376,282 | |||||||
Loading xslF345X03/tv502207_4.xml…